Erasca CMO's Direct Stake Goes to Zero: Investor Implications
When a company's top medical officer sells a large block and leaves with a zero direct stake, investors notice. This ...
Index funds and ETFs offer low-cost, diversified exposure to the market. This intro explains how they differ and when each might suit your investing goals.
28,486 articlesWhen a company's top medical officer sells a large block and leaves with a zero direct stake, investors notice. This ...
Even as global drinking declines, Anheuser-Busch InBev shows resilience through a diversified brand mix, cost discipl...
When rates trend downward, cash-flow investors face a tougher math as prices rise and competition heats up. This guid...
Microsoft stock is drawing fresh attention as investors weigh AI demand against execution risk. With a trailing P/E n...
Greg Abel’s early moves at Berkshire Hathaway signal a new investment ethos. This analysis breaks down the rationale,...
When wealth and fame meet legal drama, discovery battles can reshape costs and outcomes. This article breaks down the...
A convincing fake bank call sent a Virginia resident on a cash handoff, revealing how scammers use authority and urge...
New real estate investors often hit a wall when income is inconsistent. DSCR loans offer a financing strategy grounde...
A seasoned pharma investor places a sizable bet on Nuvation Bio as a promising drug moves forward. Learn how insider ...
A director sold 45,000 LUMN shares, triggering questions about Lumen Technologies stock sell signals. This article br...
Biotech investing offers life-changing upside, but it also comes with steep risks. This guide breaks down whether cou...
A veteran macro strategist says the classic college route may not pay off for today’s youth. He points to skilled tra...